Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Flick, H; Arns, BM; Bolitschek, J; Bucher, B; Cima, K; Gingrich, E; Handzhiev, S; Hochmair, M; Horak, F; Idzko, M; Jaksch, P; Kovacs, G; Kropfmüller, R; Lamprecht, B; Löffler-Ragg, J; Meilinger, M; Olschewski, H; Pfleger, A; Puchner, B; Puelacher, C; Prior, C; Rodriguez, P; Salzer, H; Schenk, P; Schindler, O; Stelzmüller, I; Strenger, V; Täubl, H; Urban, M; Wagner, M; Wimberger, F; Zacharasiewicz, A; Zwick, RH; Eber, E.
[Statement of the Austrian Society of Pneumology (ASP)].
Wien Klin Mag. 2020; 23(3):92-115
Doi: 10.1007/s00740-020-00350-4
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
- Eber Ernst
- Flick Holger
- Co-authors Med Uni Graz
- Kovacs Gabor
- Olschewski Horst
- Pfleger Andreas
- Strenger Volker
- Wagner Marlies
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The COVID-19 pandemic is currently a challenge worldwide. In Austria, a crisis within the health care system has so far been avoided. The treatment of patients with community-acquired pneumonia (CAP), including SARS-CoV‑2 infections, should continue to be based on evidence-based CAP guidelines during the pandemic. However, COVID-19-specific adjustments are useful. The treatment of patients with chronic lung diseases must be adapted during the pandemic, but must still be guaranteed.